Literature DB >> 18923189

Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn't the stomach digest itself?

John L Wallace1.   

Abstract

Except in rare cases, the stomach can withstand exposure to highly concentrated hydrochloric acid, refluxed bile salts, alcohol, and foodstuffs with a wide range of temperatures and osmolarity. This is attributed to a number of physiological responses by the mucosal lining to potentially harmful luminal agents, and to an ability to rapidly repair damage when it does occur. Since the discovery in 1971 that prostaglandin synthesis could be blocked by aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs), there has been great interest in the contribution of prostaglandins to gastric mucosal defense. Prostaglandins modulate virtually every aspect of mucosal defense, and the importance of this contribution is evident by the increased susceptibility of the stomach to injury following ingestion of an NSAID. With chronic ingestion of these drugs, the development of ulcers in the stomach is a significant clinical concern. Research over the past two decades has helped to identify some of the key events triggered by NSAIDs that contribute to ulcer formation and/or impair ulcer healing. Recent research has also highlighted the fact that the protective functions of prostaglandins in the stomach can be carried out by other mediators, in particular the gaseous mediators nitric oxide and hydrogen sulfide. Better understanding of the mechanisms through which the stomach is able to resist injury in the presence of luminal irritants is helping to drive the development of safer anti-inflammatory drugs, and therapies to accelerate and improve the quality of ulcer healing.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18923189     DOI: 10.1152/physrev.00004.2008

Source DB:  PubMed          Journal:  Physiol Rev        ISSN: 0031-9333            Impact factor:   37.312


  156 in total

1.  The metabolism and pharmacokinetics of phospho-sulindac (OXT-328) and the effect of difluoromethylornithine.

Authors:  G Xie; T Nie; G G Mackenzie; Y Sun; L Huang; N Ouyang; N Alston; C Zhu; O T Murray; P P Constantinides; L Kopelovich; B Rigas
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

2.  Regulation of gastric motility and blood flow during acute nociceptive stimulation of the paraspinal muscles in urethane-anaesthetised rats.

Authors:  Mathieu Piché; Nobuhiro Watanabe; Harumi Hotta
Journal:  J Physiol Sci       Date:  2013-09-15       Impact factor: 2.781

Review 3.  Gastrointestinal Perforations with Biologics in Patients with Rheumatoid Arthritis: Implications for Clinicians.

Authors:  Aprajita Jagpal; Jeffrey R Curtis
Journal:  Drug Saf       Date:  2018-06       Impact factor: 5.606

4.  Cyclic Sulfenyl Thiocarbamates Release Carbonyl Sulfide and Hydrogen Sulfide Independently in Thiol-Promoted Pathways.

Authors:  Yu Zhao; Andrea K Steiger; Michael D Pluth
Journal:  J Am Chem Soc       Date:  2019-08-14       Impact factor: 15.419

5.  The 5-HT4 receptor agonist mosapride attenuates NSAID-induced gastric mucosal damage.

Authors:  Masahiko Fujisawa; Takahisa Murata; Masatoshi Hori; Hiroshi Ozaki
Journal:  J Gastroenterol       Date:  2009-12-10       Impact factor: 7.527

Review 6.  Anti-cancer activity of new designer hydrogen sulfide-donating hybrids.

Authors:  Khosrow Kashfi
Journal:  Antioxid Redox Signal       Date:  2013-06-07       Impact factor: 8.401

7.  Effect of selenium and grape seed extract on indomethacin-induced gastric ulcers in rats.

Authors:  Amr M Abbas; Hussein F Sakr
Journal:  J Physiol Biochem       Date:  2013-03-01       Impact factor: 4.158

Review 8.  Rebamipide helps defend against nonsteroidal anti-inflammatory drugs induced gastroenteropathy: a systematic review and meta-analysis.

Authors:  Shaoheng Zhang; Qing Qing; Yang Bai; Hua Mao; Wei Zhu; Qikui Chen; Yali Zhang; Ye Chen
Journal:  Dig Dis Sci       Date:  2013-02-28       Impact factor: 3.199

Review 9.  Nitric oxide in the gastrointestinal tract: opportunities for drug development.

Authors:  John L Wallace
Journal:  Br J Pharmacol       Date:  2018-12-03       Impact factor: 8.739

10.  Ulcerogenic and intestinal motility/transit stimulating actions of nevirapine in albino Wistar rats.

Authors:  Elizabeth Bassey Umoren; Agona Odeh Obembe; Eme Effiom Osim
Journal:  J Physiol Biochem       Date:  2013-03-28       Impact factor: 4.158

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.